Why the study?
This study aimed to examine the prevalence and long-term survival of atrial fibrillation in the older population.
In an older population, AF has a prevalence of nearly 5% and is associated with a significantly increased risk of mortality over 10 years, highlighting the underutilization of anticoagulant therapy.
Answers are grounded in this paper and cite their sources.
AF associated with higher mortality in older adults; leaves open whether screening or anticoagulation alters outcomes.
Objective: This study examined the prevalence and long-term survival of atrial fibrillation (AF) in the older population. Methods: Data was recruited from the longitudinal SNAC study from baseline (2001–2004) for up to 10 years. Results: The population comprised 6,904 persons (59% women) (mean age 73.9 years). The prevalence of AF was 4.9% and increased with age. The hazard ratio (HR) for death in those with AF at baseline was 1.29 during the 10-year observation period. Cox regression analysis in persons with AF ( n = 341) showed that men had a higher HR for death (1.57). CHA2DS2-VASc scores were significantly associated with death within 10 years (HR 1.29/score). Any form of anticoagulant use was reported in 146 (42.8%) and was significantly associated with survival ( p = .031). Conclusions: The prevalence of AF in the general population was almost 5%, and it shortened life expectancy by nearly 2.4 years over a 10-year period. Despite the proven efficacy of OAC therapies, our results demonstrate that AF continues to be associated with increased mortality, especially among men, and that many older people are at high risk of developing a stroke because they do not receive appropriate anticoagulant therapy. These results emphasize the need for improved preventive and therapeutic modalities.
No takes yet. Share an insight, caveat, or question.
Lindberg et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: